45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
19,390
Insurances with rates
19
CPT / HCPCS codes
13,191
Source MRF
Most expensive procedures (gross)
J0225
$250,637
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$596,755
J0225
$250,637
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$596,755
J1823
$91,700
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$218,333
J1823
$91,700
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$218,333
J2351
$86,692
OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN
Gross
$206,410
J2351
$86,692
OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN
Gross
$206,410
C9293
$86,465
GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION
Gross
$205,870
C9293
$86,465
GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION
Gross
$205,870
J9228
$74,568
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$177,544
J9228
$74,568
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$177,544
J1747
$53,690
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$127,833
J1747
$53,690
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$127,833
J2327
$45,360
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE
Gross
$108,000
J2327
$45,360
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE
Gross
$108,000
J2350
$41,400
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$98,572
J2350
$41,400
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$98,572
0424T
$39,178
HC INS RPLC NSTIM SYSTEM SLEEP APNEA COMPLETE
Gross
$93,281
0424T
$39,178
HC INS RPLC NSTIM SYSTEM SLEEP APNEA COMPLETE
Gross
$93,281
J9309
$37,946
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$90,347
J9309
$37,946
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$90,347
33276
$36,960
HC INSJ PHRNC NRV STIM SYS
Gross
$88,001
33276
$36,960
HC INSJ PHRNC NRV STIM SYS
Gross
$88,001
A9543
$36,036
HC RP YTTRIUM 90 ZEVALIN
Gross
$85,800
A9543
$36,036
HC RP YTTRIUM 90 ZEVALIN
Gross
$85,800
J0638
$35,960
CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$85,619
J0638
$35,960
CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$85,619
J9334
$33,123
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN
Gross
$78,865
J9334
$33,123
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN
Gross
$78,865
J3241
$32,490
TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION
Gross
$77,358
J3241
$32,490
TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION
Gross
$77,358
J2507
$32,311
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$76,930
J2507
$32,311
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$76,930
J9298
$30,518
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$72,662
J9298
$30,518
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$72,662
27830849
$30,135
HC IMPELLA 5.5 W SMARTASST
Gross
$71,750
27830849
$30,135
HC IMPELLA 5.5 W SMARTASST
Gross
$71,750
J1628
$29,519
GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE
Gross
$70,283
J1628
$29,519
GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE
Gross
$70,283
33264
$28,345
HC ICD REM REPLACE BI V
Gross
$67,487
33264
$28,345
HC ICD REM REPLACE BI V
Gross
$67,487
J3245
$27,967
TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$66,589
J3245
$27,967
TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$66,589
27820331
$27,720
HC MITRACLIP 1 CLIP KIT
Gross
$66,000
27820331
$27,720
HC MITRACLIP 1 CLIP KIT
Gross
$66,000
27830918
$26,829
HC WEB SINGLE 8X5
Gross
$63,878
27830918
$26,829
HC WEB SINGLE 8X5
Gross
$63,878
27830823
$26,460
HC IMP SYS PASCAL PRECSN
Gross
$63,000
27830823
$26,460
HC IMP SYS PASCAL PRECSN
Gross
$63,000
J3357
$25,400
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$60,477
J3357
$25,400
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$60,477
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $596,755 | $250,637 | $358,053 | $507,242 | 3 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $596,755 | $250,637 | $107,416 | $507,242 | 12 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $218,333 | $91,700 | $131,000 | $185,583 | 3 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $218,333 | $91,700 | $411 | $185,583 | 35 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN | $206,410 | $86,692 | $123,846 | $175,448 | 3 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN | $206,410 | $86,692 | $37,154 | $175,448 | 12 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $205,870 | $86,465 | $123,522 | $174,990 | 3 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $205,870 | $86,465 | $37,057 | $174,990 | 12 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $177,544 | $74,568 | $106,526 | $150,912 | 3 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $177,544 | $74,568 | $144 | $150,912 | 35 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $127,833 | $53,690 | $76,700 | $108,658 | 3 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $127,833 | $53,690 | $23,010 | $108,658 | 12 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $108,000 | $45,360 | $64,800 | $91,800 | 3 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $108,000 | $45,360 | $19,440 | $91,800 | 12 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $98,572 | $41,400 | $59,143 | $83,786 | 3 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $98,572 | $41,400 | $51.16 | $83,786 | 35 |
| 0424T | HC INS RPLC NSTIM SYSTEM SLEEP APNEA COMPLETE | $93,281 | $39,178 | $55,969 | $79,289 | 3 |
| 0424T | HC INS RPLC NSTIM SYSTEM SLEEP APNEA COMPLETE | $93,281 | $39,178 | $16,791 | $79,289 | 14 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $90,347 | $37,946 | $54,208 | $76,795 | 3 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $90,347 | $37,946 | $106 | $76,795 | 35 |
| 33276 | HC INSJ PHRNC NRV STIM SYS | $88,001 | $36,960 | $52,801 | $74,801 | 3 |
| 33276 | HC INSJ PHRNC NRV STIM SYS | $88,001 | $36,960 | $15,840 | $74,801 | 10 |
| A9543 | HC RP YTTRIUM 90 ZEVALIN | $85,800 | $36,036 | $51,480 | $72,930 | 3 |
| A9543 | HC RP YTTRIUM 90 ZEVALIN | $85,800 | $36,036 | $15,444 | $151,610 | 23 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $85,619 | $35,960 | $51,371 | $72,776 | 3 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $85,619 | $35,960 | $107 | $72,776 | 35 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN | $78,865 | $33,123 | $47,319 | $67,035 | 3 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN | $78,865 | $33,123 | $14,196 | $67,035 | 12 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $77,358 | $32,490 | $46,415 | $65,754 | 3 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $77,358 | $32,490 | $285 | $65,754 | 35 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $76,930 | $32,311 | $46,158 | $65,391 | 3 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $76,930 | $32,311 | $2,927 | $65,391 | 35 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $72,662 | $30,518 | $43,597 | $61,763 | 3 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $72,662 | $30,518 | $13,079 | $61,763 | 12 |
| 27830849 | HC IMPELLA 5.5 W SMARTASST | $71,750 | $30,135 | $43,050 | $60,988 | 3 |
| 27830849 | HC IMPELLA 5.5 W SMARTASST | $71,750 | $30,135 | $12,915 | $60,988 | 17 |
| J1628 | GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE | $70,283 | $29,519 | $42,170 | $59,741 | 3 |
| J1628 | GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE | $70,283 | $29,519 | $72.96 | $59,741 | 33 |
| 33264 | HC ICD REM REPLACE BI V | $67,487 | $28,345 | $40,492 | $57,364 | 3 |
| 33264 | HC ICD REM REPLACE BI V | $67,487 | $28,345 | $726 | $69,366 | 34 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $66,589 | $27,967 | $39,953 | $56,601 | 3 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $66,589 | $27,967 | $113 | $56,601 | 35 |
| 27820331 | HC MITRACLIP 1 CLIP KIT | $66,000 | $27,720 | $39,600 | $56,100 | 3 |
| 27820331 | HC MITRACLIP 1 CLIP KIT | $66,000 | $27,720 | $11,880 | $56,100 | 17 |
| 27830918 | HC WEB SINGLE 8X5 | $63,878 | $26,829 | $38,327 | $54,296 | 3 |
| 27830918 | HC WEB SINGLE 8X5 | $63,878 | $26,829 | $11,498 | $54,296 | 17 |
| 27830823 | HC IMP SYS PASCAL PRECSN | $63,000 | $26,460 | $37,800 | $53,550 | 3 |
| 27830823 | HC IMP SYS PASCAL PRECSN | $63,000 | $26,460 | $11,340 | $53,550 | 17 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $60,477 | $25,400 | $36,286 | $51,406 | 3 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $60,477 | $25,400 | $134 | $51,406 | 35 |
Showing top 50 of 19,390 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.